Aeolus Pharmaceuticals (AOLS)

[HDOGTX]

AOLS AEOLUS PHARMACEUTICALS, INC. FILES (8-K) Disclosing Other Events Edgar Online "Glimpses"
Item 8.01. Other Events On February 19, 2016 , Aeolus Pharmaceuticals, Inc. (the "Company") received notice from the U.S. Food & Drug Administration ("FDA") that the clinical hold on the safety study in healthy normal volunteers proposed in its Investigational New Drug Application ("IND") for AEOL 10150 in the pulmonary effects of Acute Radiation Syndrome ("Lung-ARS") has been removed. The Company plans to initiate the proposed safety study as soon as practicable.

http://archive.fast-edgar.com//20160223/AI2BO22C8222V2Z222222CNGQUARZ222N282/